SCHEMBL30568614

SCHEMBL30568614

Fc1cc(Br)ccc1-n1ncc2c(Cl)ncnc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
TRAP1 Q12931 1/20 0.42
CYP17A1 P05093 4/20 0.41
CYP1A2 P05177 2/20 0.39
RAB9A P51151 3/20 0.39
TP53 P04637 6/20 0.38
LMNA P02545 3/20 0.38
POLB P06746 1/20 0.38
SLC2A1 P11166 2/20 0.37
SLC2A2 P11168 2/20 0.37
SLC2A3 P11169 2/20 0.37
MAPT P10636 3/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PIP4K2A P48426 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
PKM P14618 1/20 0.36
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL839701 0.86 CYP17A1 (0.53) CYP17A1CYP1A2RAB9ATP53LMNA
SCHEMBL30568414 0.86 CYP17A1 (0.53) CYP17A1CYP1A2RAB9ATP53LMNA
SCHEMBL12414250 0.84 RAB9A (0.53) CYP17A1CYP1A2RAB9ATP53LMNA
SCHEMBL25342676 0.84 CYP17A1 (0.41) CYP17A1CYP1A2RAB9ATP53LMNA
SCHEMBL30568436 0.82 CYP17A1 (0.42) CYP17A1CYP1A2RAB9ATP53LMNA
SCHEMBL25343909 0.82 CYP17A1 (0.42) CYP17A1CYP1A2RAB9ATP53LMNA
SCHEMBL25345923 0.81 SLC2A1 (0.41) CYP17A1CYP1A2RAB9ATP53LMNA
SCHEMBL12000946 0.81 SLC2A1 (0.53) CYP1A2RAB9ATP53LMNASLC2A1
SCHEMBL25341748 0.79 GSK3B (0.40) CYP17A1CYP1A2RAB9ATP53LMNA
SCHEMBL1243507 0.79 GPR119 (0.53) CYP17A1CYP1A2RAB9ATP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4472739-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2024-12-11 EP disclosed
WO-2023148129-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2023-08-10 WO disclosed